Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development

Abstract

ADAM9, EFNB2, MET, TMOD3, TPX2, and WNT7A are potent antigens for developing anti-PAAD mRNA vaccine, and patients with IS4 and IS5 tumors are suitable for vaccination.